Electrochemotherapy for the Inoperable Vulva Carcinoma

Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma

Electrochemotherapy (ECT) with Bleomycin in non-operable advanced vulva carcinoma

Prospective evaluation of tumor response towards ECT by photo documentation. In addition prospective documentation of life quality after ECT treatment as well as evaluation of pain. .

Inclusion Criteria:

• informed consent
• age ≥ 55 years (postmenopausal)
• histologically proved cutan accessible vulva carcinoma
• a maximum of 5 lesions ≥1 - ≤ 5 cm diameter; a maximum thickness of 3 cm
• applied electrochemotherapy with electroporation

Exclusion Criteria:

• Non compliant patients
• Patients with symptomatic or rapidly progredient metastasis outside of the vulva